Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (14)

2023

  1. Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties

    European Journal of Medicinal Chemistry, Vol. 255

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Synthesis of sp2-Iminosugar Selenoglycolipids as Multitarget Drug Candidates with Antiproliferative, Leishmanicidal and Anti-Inflammatory Properties

    Molecules (Basel, Switzerland), Vol. 26, Núm. 24

2020

  1. Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study

    Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170

  2. Metastatic versus osteoporotic vertebral fractures on MRI: A blinded, multicenter, and multispecialty observer agreement evaluation

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 18, Núm. 3, pp. 267-273

  3. Prevalence of ankylosing spondylitis in Spain: EPISER2016 Study

    Scandinavian Journal of Rheumatology, Vol. 49, Núm. 3, pp. 210-213

  4. The prevalence of rheumatoid arthritis in Spain

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96

  2. Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies

    European Journal of Medicinal Chemistry, Vol. 182

2016

  1. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

  2. Spine Instability Neoplastic Score: agreement across different medical and surgical specialties

    Spine Journal, Vol. 16, Núm. 5, pp. 591-599

2015

  1. Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

    Gastroenterologia y Hepatologia, Vol. 38, Núm. 4, pp. 263-273

2007

  1. Displasia de alto grado como factor de riesgo de neoplasia colorrectal avanzada metacrónica, en pacientes con adenomas avanzados

    Gastroenterologia y Hepatologia, Vol. 30, Núm. 4, pp. 207-211

2006

  1. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain

    Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658